TNF and dermatomyositis: Remarkably, there are reports in the literature on new onset of DM, PM or ASS after initiation of anti-TNF-α treatment in patients affected by other diseases, e.g. rheumatoid arthritis (reviewed in [64]), although it remains unclear whether TNF-α-inhibition triggered a general immunological adverse reaction or specifically induced an unwanted inflammation in the skeletal muscle.